BenzingaAugust 27, 2026 at 3:14 AM NY8 days ago

Cantor Fitzgerald Reiterates Overweight on Invivyd, Maintains $10 Price Target

Cantor Fitzgerald analyst Josh Schimmer reiterates Invivyd (NASDAQ:IVVD) with a Overweight and maintains $10 price target.

Read the Full Story at the Source

The summary here comes from the news provider; the rest of the article lives on the publisher's site — Benzinga

Companies in This Story